Search - tctmd.com

Displaying 921 - 940 of 7252

Sort: Relevancy | Date

Presentation ESC 2024

Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial

Presenter: Byeong-Keuk Kim

September 02, 2024

Presentation ESC 2024

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

Presenter: Derek Chew

September 02, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Presentation ESC 2024

BedMed and BedMed-Frail randomized controlled trials

Presenter: Scott Garrison

August 31, 2024

Presentation ESC 2024

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Presenter: Stefano Taddei

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation ESC 2024

The ASSURE DES Randomized Clinical Trial

Presenter: Jung-Min Ahn

August 31, 2024

Presentation NY Valves 2024

Interventional Approaches to Septal Reduction Therapy

Presenter: Srihari S. Naidu

June 07, 2024

Presentation NY Valves 2024

Transeptal TMVR – Have Technology Developments Met Clinical Expectations?

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

Is there Still a Role for Surgery in HCM?

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

Global Experience With Transapical TMVR - Does Access Impact Clinical Outcomes?

Presenter: Michael J. Reardon

June 07, 2024

Presentation NY Valves 2024

Myosin Inhibitors and Novel Medical Therapies for HCM

Presenter: Mark V. Sherrid

June 07, 2024

Presentation NY Valves 2024

The SESAME Procedure for Obstructive HCM.

Presenter: Jaffar M. Khan

June 07, 2024

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Ongoing Research Clinical Research – Impact on Future Guidelines?

Presenter: Dimosthenis Pandis

June 07, 2024

Presentation NY Valves 2024

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Presenter: Eric Horlick

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Advertisement

Optical coherence tomography-guided coronary intervention in patients with complex lesions: The OCCUPI Randomized Clinical Trial

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

BedMed and BedMed-Frail randomized controlled trials

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Continuation versus Interruption of Oral Anticoagulation during TAVI

The ASSURE DES Randomized Clinical Trial

Interventional Approaches to Septal Reduction Therapy

Transeptal TMVR – Have Technology Developments Met Clinical Expectations?

Is there Still a Role for Surgery in HCM?

Global Experience With Transapical TMVR - Does Access Impact Clinical Outcomes?

Myosin Inhibitors and Novel Medical Therapies for HCM

The SESAME Procedure for Obstructive HCM.

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Ongoing Research Clinical Research – Impact on Future Guidelines?

What Is the Future of Percutaneous Tricuspid Valve Procedures?

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content